Wave Life Sciences
162 hedge funds and large institutions have $986M invested in Wave Life Sciences in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 61 increasing their positions, 38 reducing their positions, and 17 closing their positions.
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
108% more capital invested
Capital invested by funds: $474M → $986M (+$512M)
61% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 38
32% more call options, than puts
Call options by funds: $1.49M | Put options by funds: $1.13M
16.28% more ownership
Funds ownership: 77.62% → 93.91% (+16%)
13% more funds holding
Funds holding: 144 → 162 (+18)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$29.6M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$26M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$14.2M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$11.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$22.8M |
| 2 |
6CM
683 Capital Management
New York
|
-$6.72M |
| 3 |
Millennium Management
New York
|
-$4.86M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$2.58M |
| 5 |
EAM
Exome Asset Management
New York
|
-$2.44M |
WVE Hedge Fund Activity: Q3 2024 in Review
162 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2024, worth a combined $986M — up 108% from $474M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new WVE positions and 17 closed out — a net gain of 19 holders — while 61 added to existing stakes and 38 trimmed.
The largest buyer was Driehaus Capital Management, adding an estimated $29.6M. The largest seller was Artal Group, exiting entirely with an estimated $22.8M sold.
- 162 institutional investors held Wave Life Sciences (WVE) as of Q3 2024, up from 144 in Q2 2024.
- Funds reported $986M of Wave Life Sciences stock for Q3 2024, up 108% quarter-over-quarter.
- 36 funds opened new Wave Life Sciences positions in Q3 2024 and 17 closed out, a net change of +19 holders.
- The largest Wave Life Sciences buyer in Q3 2024 was Driehaus Capital Management, an estimated $29.6M added.
- The largest Wave Life Sciences seller in Q3 2024 was Artal Group, an estimated $22.8M sold.
Based on aggregated 13F filings for Q3 2024.